Similarly, for meningitis and bronchitis the bacterial counts can be as high as 109 per ml, and overall these data suggest that the total bacterial population sizes in an infected individual typically is so high that pre-existing AMP resistant mutants are expected to be present (i.e. population size x mutation rate >1) when treatment is initiated.